FOGHORN THERAPEUTICS INC (FHTX) Stock Income Statement
NASDAQ:FHTX - US3441741077 - Common Stock
5.56 USD
+0.52 (+10.32%)
5.56 USD
0 (0%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 24.17M | 22.60M | 34.16M | 19.23M | 1.32M | |||
| Operating Expenses | 116.04M | 122.89M | 142.06M | 136.37M | 102.06M | |||
| Research and Development | 88.61M | 94.53M | 109.69M | 105.62M | 80.33M | |||
| Selling, General, and Administrative Expenses | 27.43M | 28.36M | 32.37M | 30.75M | 21.73M | |||
| Operating Income | -91.87M | -100.28M | -107.91M | -117.14M | -100.74M | |||
| Interest Income/Expense | 11.59M | 11.90M | 10.88M | 5.68M | -1.91M | |||
| Other Income/Expense | 4.88M | 4.16M | 2.83M | 2.58M | 2.55M | |||
| Non Recurring Items | N/A | -2.40M | N/A | 0.00 | -1.23M | |||
| Income Before Taxes | -75.39M | -86.62M | -94.20M | -108.88M | -101.32M | |||
| Income Tax | N/A | 0.00 | 4.23M | N/A | N/A | |||
| Net Income | -75.39M | -86.62M | -98.43M | -108.88M | -101.32M | |||
| EBITDA | -88.69M | -97.17M | -104.45M | -113.84M | -97.54M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.20 | -1.58 | -2.34 | -2.62 | -2.73 | |||
| Non GAAP EPS | -1.19 | -1.65 | -2.34 | -2.62 | -2.70 | |||
| Statistics | ||||||||
| Profit Margin | -311.90% | -383.24% | -288.17% | -566.20% | -7675.76% | |||
| Operating Profit Margin | -380.04% | -443.70% | -315.93% | -609.15% | -7631.82% | |||
All data in USD